PBX1 is a valuable prognostic biomarker for patients with breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PBX1 is a valuable prognostic biomarker for patients with breast cancer

Published:2020-04-30 Issue:1 Volume:20 Page:385-394
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Ao Xiang¹,Ding Wei²,Ge Hu¹,Zhang Yuan¹,Ding Dan¹,Liu Ying¹^ORCID

Affiliation:

1. Center for Precision Medicine, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, Shandong 266021, P.R. China

2. Department of Comprehensive Internal Medicine, Affiliated Hospital, Qingdao University, Qingdao, Shandong 266021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer;Cancer Genetics;2024-04

2. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

3. PBX1: a TALE of two seasons—key roles during development and in cancer;Frontiers in Cell and Developmental Biology;2024-02-09

4. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis;Journal of Thoracic Oncology;2023-08

5. Correlation analysis of PBX family with immune invasion and drug sensitivity in colon adenocarcinoma;Heliyon;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP